Physician profile
Tracy D Carter
NPI 1922235258
$1,813.98
in general payments reported to CMS, 2019-2025
14 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $88.26 · 2021: $405 · 2022: $293 · 2023: $183 · 2024: $402 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $716.29 | 2021-2025 | Clareon, Argos |
| Harrow Eye, LLC | $187.95 | 2024-2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $150.23 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $116.14 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $111.30 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $110.47 | 2023-2025 | Tyrvaya, Ryzumvi |
| Kala Pharmaceuticals, INC. | $89.81 | 2019-2021 | |
| Allergan, INC. | $83.58 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $83.24 | 2024-2025 | Tecnis Simplicity, Tecnis Iol |
| Dompe US, INC. | $49.56 | 2024-2025 | Oxervate |
| Abbvie INC. | $40.41 | 2024-2025 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Ivantis, INC | $19.77 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.